Logo image
Development of a microfluidic device for detection of pathogens in oral samples using upconverting phosphor technology (UPT)
Journal article

Development of a microfluidic device for detection of pathogens in oral samples using upconverting phosphor technology (UPT)

William R Abrams, Cheryl A Barber, Kurt McCann, Gary Tong, Zongyuan Chen, Michael G Mauk, Jing Wang, Alex Volkov, Pete Bourdelle, Paul L A M Corstjens, …
Annals of the New York Academy of Sciences, v 1098(1), pp 375-388
Mar 2007
PMID: 17435143

Abstract

Saliva - immunology Saliva - virology Microfluidics - instrumentation Humans Saliva - microbiology Saliva - chemistry Luminescent Measurements - methods Microfluidics - methods Antigen-Antibody Reactions Luminescent Measurements - instrumentation
Confirmatory detection of diseases, such as HIV and HIV-associated pathogens in a rapid point-of-care (POC) diagnostic remains a goal for disease control, prevention, and therapy. If a sample could be analyzed onsite with a verified result, the individual could be counseled immediately and appropriate therapy initiated. Our group is focused on developing a microfluidic "lab-on-a-chip" that will simultaneously identify antigens, antibodies, RNA, and DNA using a single oral sample. The approach has been to design individual modules for each assay that uses similar components (e.g., valves, heaters, metering chambers, mixers) installed on a polycarbonate base with a common reporter system. Assay miniaturization reduces the overall analysis time, increases accuracy by simultaneously identifying multiple targets, and enhances detector sensitivity by upconverting phosphor technology (UPT). Our microfluidic approach employs four interrelated components: (1) sample acquisition-OraSure UPlink collectors that pick-up and release bacteria, soluble analytes, and viruses from an oral sample; (2) microfluidic processing-movement of microliter volumes of analyte, target analyte extraction and amplification; (3) detection of analytes using UPT particles in a lateral flow system; and (4) software for processing the results. Ultimately, the oral-based microscale diagnostic system will detect viruses and bacteria, associated pathogen antigens and nucleic acids, and antibodies to these pathogens.

Metrics

14 Record Views
34 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Dentistry, Oral Surgery & Medicine
Medical Laboratory Technology
Logo image